EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets

Pengcheng Chang, Zitong Qin, Runzhang Liu, Binxian Wang, Huaiquan Lu, Suoshi Jing, Chenhao Guo, Weiping Li

Frontiers in Oncology · 08.07.2026 · 16

DOI: 10.3389/fonc.2026.1857894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 08.07.2026. Verfasst von Pengcheng Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma (ccRCC) is a prevalent malignancy, representing 80−90% of kidney cancer cases. This study aimed to identify potential prognostic genes to improve patient survival prediction and provide new insights into the pathogenesis and treatment of ccRCC through comprehensive whole transcriptome sequencing analysis.

Methods

The analysis utilized whole transcriptomic data from publicly available datasets, including TCGA-KIRC and GSE96574. Methods involved identifying differentially expressed mRNAs and long non-coding RNAs, prognostic gene screening via MCODE plugin and risk model construction, followed by functional enrichment, molecular network construction, drug prediction, and molecular docking. The expression levels of key genes were subsequently validated using reverse transcription quantitative PCR (RT−qPCR) on clinical samples.

Results

Eight prognostic genes (IFNG, CXCL13, KLRK1, LAG3, ITGAX, TNFRSF9, CD2, CD8B) were identified and formed a risk stratification model. These genes were primarily enriched in immune-related pathways such as antigen processing and presentation. A regulatory network involving transcription factors, miRNAs, lncRNA PVT1, and circRNAs was constructed. Drug prediction and molecular docking suggested potential targeted drugs, including amitriptyline hydrochloride for CD8B and IFNG, and rituximab for CXCL13 and IFNG, with strong binding affinities noted for ITGAX and KLRK1. RT−qPCR validation confirmed significantly elevated expression of IFNG, LAG3, TNFRSF9, and CD8B in ccRCC patients compared to controls (p < 0.05).

Conclusions

This study identifies an eight-gene signature as a promising prognostic biomarker for ccRCC, deeply involved in the tumor immune microenvironment. The findings offer novel insights into ccRCC pathogenesis and highlight potential therapeutic targets and agents, paving the way for improved prognostic strategies and immunotherapeutic approaches.

Schlagwörter

Stichwörter der Autor:innen

clear cell renal cell carcinomaprognostic genesregulatory networkrisk modelwhole transcriptome sequencing

Autor:innen und Institutionen

  • Department of Urology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
  • The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.

Zitieren

APA

Chang, P., Qin, Z., Liu, R., Wang, B., Lu, H., Jing, S., Guo, C., & Li, W. (2026). Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1857894

Vancouver

Chang P, Qin Z, Liu R, Wang B, Lu H, Jing S, et al. Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1857894

BibTeX
@article{Chang2026,
  author = {Chang, Pengcheng and Qin, Zitong and Liu, Runzhang and Wang, Binxian and Lu, Huaiquan and Jing, Suoshi and Guo, Chenhao and Li, Weiping},
  title = {Identification and validation of prognostic genes associated with clear cell renal cell carcinoma: based on public whole transcriptome sequencing datasets},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1857894}
}
Kostenlos starten →